Iren Limited (IREN) shares tanked on Aug. 28 as investors panicked over a $684 million quarterly loss driven by non-cash impairments and massive upcoming capital expenditures. But the market’s reaction to IREN’s earnings release overlooks a major positive: the Nasdaq-listed firm has locked in $4 billion in contracted annualized recurring revenue (ARR) for 2026.
Following the post-earnings decline, IREN stock is trading at nearly half its price in late May.